<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3593">
  <stage>Registered</stage>
  <submitdate>11/07/2012</submitdate>
  <approvaldate>11/07/2012</approvaldate>
  <nctid>NCT01642797</nctid>
  <trial_identification>
    <studytitle>Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma</studytitle>
    <scientifictitle>Confocal Laser Endomicroscopy for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma: A Multicenter, Randomized, Controlled Trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>20120621</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Gastric Intestinal Metaplasia</healthcondition>
    <healthcondition>Gastric Intraepithelial Neoplasia</healthcondition>
    <healthcondition>Gastric Carcinoma</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Non melanoma skin cancer</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Kidney</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Cervical (cervix)</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Breast</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Stomach</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Confocal laser endomicroscopy (Pentax, EG3870K)
Treatment: devices - Standard White-light endoscopy (Pentax, 90i)

Experimental: CLE-TB - Confocal laser endomicroscopy with Targeted Biopsy

Experimental: WLE-SB - Standard White-light endoscopy with Standard Biopsy


Treatment: devices: Confocal laser endomicroscopy (Pentax, EG3870K)
Confocal laser endomicroscopy with Targeted Biopsy

Treatment: devices: Standard White-light endoscopy (Pentax, 90i)
Standard White-light endoscopy with Standard Biopsy

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>number of participant with gastric IM/IN/CA - To determine whether CLE with optical biopsy and targeted mucosal biopsy improves the diagnostic yield of gastric IM/IN/CA in high risk populations compared to WLE with standard biopsy protocol.</outcome>
      <timepoint>1 year</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>number of biopsies needed per patient - To determine whether CLE with optical biopsy and targeted biopsy, as compared to WLE with standard biopsy, can reduce the number of biopsies needed per patient for detection of gastric IM/IN/CA without the loss of corresponding diagnostic yield.</outcome>
      <timepoint>1 year</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Male or Female aged 18-80

          -  Patients with H. pylori infection, or histologically verified gastric intestinal
             metaplasia, low-grade intraepithelial neoplasia, and atrophic gastritis</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients with gastrectomy, acute GI bleeding, and advanced gastric cancer

          -  Patients under conditions unsuitable for performing CLE including coagulopathy,
             impaired renal function, pregnancy or breastfeeding, and known allergy to fluorescein
             sodium

          -  Inability to provide informed consent and other situations that could interfere with
             the examination protocol</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>242</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/09/2013</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>the University of New South Wales, Bankstown-Lidcombe Hospital - Bankstown</hospital>
    <postcode> - Bankstown</postcode>
    <countryoutsideaustralia>
      <country>China</country>
      <state>Hongkong</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>China</country>
      <state>Shandong</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Singapore</country>
      <state>Singapore</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Shandong University</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Prince of Wales Hospital, Shatin, Hong Kong</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>National University Hospital, Singapore</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of New South Wales</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>i. To determine whether Confocal Laser Endomicroscopy (CLE) with optical biopsy and targeted
      mucosal biopsy improves the diagnostic yield of gastric IM/IN/CA in high risk populations
      compared to WLE with standard biopsy protocol.

      ii. To determine whether CLE with optical biopsy and targeted biopsy, as compared to WLE with
      standard biopsy, can reduce the number of biopsies needed per patient for detection of
      gastric IM/IN/carcinoma without the loss of corresponding diagnostic yield.

      iii. To compare the sensitivity and specificity of CLE with WLE for the detection of gastric
      IM/IN/CA.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01642797</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Yanqing Li, PhD. MD.</name>
      <address />
      <phone>86-531-8216923</phone>
      <fax />
      <email>qiluliyanqign@gmail.com</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>